Hide

FocusBar

Subscribe to Premium Member
Bruce Berkowitz

Bruce Berkowitz

Last Update: 2013-05-15

Number of Stocks: 21
Number of New Stocks: 3

Total Value: $7,860 Mil
Q/Q Turnover: 6%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:
Please Subscribe to see portfolio changes after 2013-03-31.

Plans start from as little as $299/year. 7-Day FREE TRIAL

Bruce Berkowitz Latest Trades :



TickerCompanyDate Action
Impact Price Range
(Average)*down
Current Price Change from Average Comment Current Shares
AIG.WS American Internation... 2011-06-30 Sold Out -1.83%$8.55 - $11.17
($9.48)
$ 6.77-29%Sold Out0
MBI Mbia Inc. 2011-06-30 Add0.38%$7.77 - $10.92
($9.15)
$ 14.862%Add 13.52%46,832,270
GS The Goldman Sachs Gr... 2011-03-31 Add0.89%$154.38 - $175
($164.5)
$ 160.73-2%Add 13.81%6,702,300
BRK.B Berkshire Hathaway 2011-03-31 Add0.59%$79.4 - $87.28
($83.37)
$ 112.735%Add 14.92%7,864,250
SHLD Sears Holdings Corp. 2011-03-31 Add0.8%$70.18 - $93.03
($80.25)
$ 59.79-26%Add 9.36%16,313,973
HUM Humana Inc. 2011-03-31 Sold Out $54.74 - $68.77
($61.03)
$ 79.5230%Sold Out0
AZN Astrazeneca Plc 2011-03-31 Buy 0.05%$45.4 - $49.38
($47.67)
$ 51.718%New holding, 155000 sh.155,000
C Citigroup Inc. 2011-03-31 Add0.65%$43.9 - $51.3
($47.29)
$ 51.669%Add 8.98%258,442,600
GSK Glaxosmithkline Plc 2011-03-31 Buy 0.05%$36.33 - $39.86
($38.17)
$ 52.6538%New holding, 190000 sh.190,000
VZ Verizon Communicatio... 2011-03-31 Reduce-1.77%$34.3 - $38.46
($36.17)
$ 52.0744%Reduce -92.67%542,700
LLY Eli Lilly & Co. 2011-03-31 Buy 0.05%$33.63 - $35.84
($34.79)
$ 55.1458%New holding, 209000 sh.209,000
WCG Wellcare Health Plan... 2011-03-31 Sold Out $29.9 - $41.44
($34.68)
$ 51.7249%Sold Out0
BAM Brookfield Asset Man... 2011-03-31 Buy 6.18%$30.45 - $33.9
($32.38)
$ 37.9717%New holding, 27500000 sh.27,500,000
T At&t Inc. 2011-03-31 Reduce-1.9%$27.33 - $30.71
($28.4)
$ 36.9430%Reduce -93.15%642,700
BMY Bristolmyers Squibb ... 2011-03-31 Buy 0.05%$24.97 - $27.29
($25.92)
$ 44.0670%New holding, 277000 sh.277,000
SPR Spirit Aerosystems H... 2011-03-31 Reduce-1.14%$20.44 - $26.16
($24.28)
$ 21.63-11%Reduce -36.97%10,949,900
TEF Telefonica S.a. 2011-03-31 Buy 0.14%$21.05 - $25.08
($23.93)
$ 14.2-41%New holding, 817500 sh.817,500
GE General Electric 2011-03-31 Sold Out $18.28 - $21.52
($19.96)
$ 23.6618%Sold Out0
CSCO Cisco Systems Inc. 2011-03-31 Buy 4.25%$17 - $22.05
($19.5)
$ 24.0123%New holding, 35818600 sh.35,818,600
GGP General Growth Prope... 2011-03-31 Sold Out $14.35 - $15.92
($15.11)
$ 22.8651%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Bruce Berkowitz's Profile:

Bruce Berkowitz is the founder and the Managing Member of the Fairholme Fund. Prior to forming Fairholme Capital Management, Mr. Berkowitz was a Managing Director of Smith Barney, Inc. from December of 1993 to October of 1997.



Bruce Berkowitz's Performance:

Average Annual Return of Fairholme Fund
5 Yrs 10 Yrs Since Inception
2.4% 10% 11.2%
» More Profile & Performance

Bruce Berkowitz's Current Portfolio:

Ticker Shares Value ($1000)
AIG85,900,0773,334,640
BAC100,589,2151,225,180
SHLD19,508,773974,853
JOE25,035,855532,012
LUK18,770,478514,874
AIG.WS24,315,718369,599
MBI31,425,820322,743
CHK13,373,700272,957
BRK.B1,530,975159,528
BAC.WS.A9,904,42856,455
» More Current Portfolio

Bruce Berkowitz's Sector Weightings:


SectorsSector Weightings (%)
Financial Services 64.3% 64.3%
Consumer Cyclical 12.4% 12.4%
Real Estate 6.8% 6.8%
Technology 6.6% 6.6%
Energy 3.9% 3.9%
» More Sector Weightings

Bruce Berkowitz's News:

» More Related News


Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK